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Discovery of minor histocompatibility antigens as targets for 
immunotherapy 
1. Discovery of minor histocompatibility antigens contributes to understanding the basic 
mechanisms behind epitope generation and development of graft-versus-leukemia-
reactivity and graft-versus-host disease. (this thesis) 
2. Forward approaches are preferable over reverse methods, since forward approaches 
enable identification of antigens that are generated by previously unknown mechanisms, 
while reverse approaches are limited to what is already known and cannot elucidate novel 
mechanisms. (this thesis) 
3. Minor histocompatibility antigens encoded by alternative transcripts form an important 
source of antigens that is overlooked by current identification methods. (this thesis) 
4. When evaluating the clinical significance of targets for immunotherapy of hematological 
malignancies, reactivity against non-hematopoietic cells cultured under inflammatory 
conditions must be assessed to ensure hematopoiesis-restricted targeting after allogeneic 
stem cell transplantation. (this thesis)   
5. Lowering the risk of severe graft-versus-host disease is the biggest hurdle to broad and 
successful application of allogeneic stem cell transplantation. (Ferrara JL et al., Lancet, 2009; 
373(9674); 1550-61) 
6. The striking results in chimeric antigen receptor T-cell therapy may be restricted to CD19 
as perfect antigen for (malignant) B-cells. (Sadelain M, J Clin Invest., 2015; 125(9); 3392-400) 
7. Neoantigens behave much like minor histocompatibility antigens, but for therapeutic use 
genetic polymorphisms should not be confused with tumor-specific mutations. 
(Schumacher TN, Schreiber RD, Science, 2015; 348(6230); 69-74) 
8. Successful allogeneic hematopoietic stem cell transplantation requires optimization and 
individualization of the time of administration and the dosages of the drugs used in the 
conditioning regimen. (Admiraal R et al., Lancet Haematol., 2015; 2(5); e194-203) 
9. How much easier it is to be critical than to be correct.  ‒ Benjamin Disraeli, 1860, British 
politician (1804-1881)  
10. Our deepest fear is not that we are inadequate. Our deepest fear is that we are powerful 
beyond measure. It is our light, not our darkness that most frightens us. ‒ Marianne 
Williamson, A Return To Love: Reflections on the Principles of A Course in Miracles, 1992 
11. On the journey to get to know (one’s own) true nature, yoga and science are 
complimentary and equally important. 
12. In order to survive in science, you must be able to let go of personal attachment to your 
projects and realize that people criticize the work and not the person. 
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